13 Einträge |
Seite 1 / 1
![]() |
Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study. |
Inaba H, Zhou Y, Abla O, Adachi S, Auvrignon A, Beverloo HB, de Bont E, Chang TT, Creutzig U, Dworzak M, Elitzur S, Fynn A, Forestier E, Hasle H, Liang DC, Lee V, Locatelli F, Masetti R, De Moerloose B, Reinhardt D, Rodriguez L, Van Roy N, Shen S, Taga T, Tomizawa D, Yeoh AE, Zimmermann M, Raimondi SC |
Blood. 2015 Jul 27. pii: blood-2015-02-629204. doi: 10.1182/blood-2015-02-629204 |
PMID: 26215111 |
Safety and efficacy of intrathecal rituximab in children with B cell lymphoid CD20+ malignancies: An international retrospective study. |
Ceppi F, Weitzman S, Woessmann W, Davies K, Lassaletta A, Bettina R, Mellgren K, Uyttebroeck A, Maia I, Abdullah S, Miakova N, Glaser D, Cohn R, Abla O, Attarbaschi A, Alexander S |
American journal of hematology. 2016 Feb 12. doi: 10.1002/ajh.24329 |
PMID: 26872652 |
Non-anaplastic peripheral T cell lymphoma in children and adolescents-an international review of 143 cases. |
Mellgren K, Attarbaschi A, Abla O, Alexander S, Bomken S, Bubanska E, Chiang A, Csóka M, Fedorova A, Kabickova E, Kapuscinska-Kemblowska L, Kobayashi R, Krenova Z, Meyer-Wentrup F, Miakova N, Pillon M, Plat G, Uyttebroeck A, Williams D, Wróbel G, Kontny U |
Annals of hematology. 2016 Jun 7. doi: 10.1007/s00277-016-2722-y. pii: 10.1007/s00277-016-2722-y |
PMID: 27270301 |
Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents. |
Attarbaschi A, Carraro E, Abla O, Barzilai-Birenboim S, Bomken S, Brugieres L, Bubanska E, Burkhardt B, Chiang AK, Csoka M, Fedorova A, Jazbec J, Kabickova E, Krenova Z, Lazic J, Loeffen J, Mann G, Niggli F, Miakova N, Osumi T, Ronceray L, Uyttebroeck A, Williams D, Woessmann W, Wrobel G, Pillon M |
Haematologica. 2016 Aug 11. pii: haematol.2016.147116. doi: 10.3324/haematol.2016.147116 |
PMID: 27515251 |
Children and adolescents with marginal zone lymphoma have an excellent prognosis with limited chemotherapy or a watch-and-wait strategy after complete resection. |
Ronceray L, Abla O, Barzilai-Birenboim S, Bomken S, Chiang AK, Jazbec J, Kabickova E, Lazic J, Beishuizen A, Mellgren K, Tanaka F, Pillon M, Devalck C, Gouttenoire M, Makarova O, Burkhardt B, Attarbaschi A |
Pediatric blood & cancer. 2017 Dec 29. doi: 10.1002/pbc.26932 |
PMID: 29286565 |
Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents. |
Attarbaschi A, Abla O, Ronceray L, Bansil S, Bomken S, Burkhardt B, Ceppi F, Chiang AKS, Dave H, Fedorova A, Henry M, Jazbec J, Kabickova E, Kotecha RS, Lazic J, Loeffen J, Miakova N, Osumi T, Pillon M, Pourtsidis A, Rigaud C, Tamamyan G, Tandon S, Uyttebroeck A, Verdu-Amoros J, Woessmann W, Wrobel G, Giulino-Roth L |
Blood advances. pii: 429992. doi: 10.1182/bloodadvances.2019001062 |
PMID: 31869415 |
Rare non-Hodgkin lymphoma of childhood and adolescence: A consensus diagnostic and therapeutic approach to pediatric-type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T-cell lymphoma. |
Attarbaschi A, Abla O, Arias Padilla L, Beishuizen A, Burke GAA, Brugières L, Bruneau J, Burkhardt B, d'Amore ESG, Klapper W, Kontny U, Pillon M, Taj M, Turner SD, Uyttebroeck A, Woessmann W, Mellgren K |
Pediatric blood & cancer. 2020 May 26. doi: 10.1002/pbc.28416 |
PMID: 32452165 |
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants. |
Cicconi L, Testi AM, Montesinos P, Rego E, Zhu HH, Takahashi H, Dworzak M, Estey E, Schwarer A, Esteve J, Annibali O, Castelli R, Mirabile M, Angelini M, Lazarevic V, Kumar J, Avvisati G, Gurnari C, Locatelli F, Voso MT, Sanz MA, Lo-Coco F, Abla O |
Blood cancer journal. 2021 Oct 16. doi: 10.1038/s41408-021-00561-w. pii: 10.1038/s41408-021-00561-w |
PMID: 34657125 |
A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome. |
Guney E, Lucas CG, Qi Z, Yu J, Zhang R, Ohgami RS, Rubenstein JL, Boué DR, Schafernak KT, Wertheim GB, Dahiya S, Giulino-Roth L, Attarbaschi A, Barth MJ, Kothari S, Abla O, Cohen AL, Mendez JS, Bollen AW, Perry A, Tihan T, Pekmezci M, Solomon DA, Wen KW |
Blood advances. 2022 Feb 14. pii: 483998. doi: 10.1182/bloodadvances.2021006018 |
PMID: 35157770 |
Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting. |
Park JR, Bagatell R, Cohn SL, Pearson AD, Villablanca JG, Berthold F, Burchill S, Boubaker A, McHugh K, Nuchtern JG, London WB, Seibel NL, Lindwasser OW, Maris JM, Brock P, Schleiermacher G, Ladenstein R, Matthay KK, Valteau-Couanet D |
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 May 4. doi: 10.1200/JCO.2016.72.0177 |
PMID: 28471719 |
• Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed-mutation rate of the marker higher than expected. |
Kappel-Latif S, Zacherl J, Hejna M, Westerhoff M, Tamandl D, Ba-Ssalamah A, Mittlböck M, Wolf B, Wrba F, Kührer I, Pluschnig U, Schoppmann SF, Függer R, Zwrtek R, Glaser K, Karner J, Längle F, Wenzl E, Roka R, Öfner D, Tschmelitsch J, Hold M, Keil F, Gnant M, Kandioler D |
European surgery : ACA : Acta chirurgica Austriaca. 2018 Jun 11. doi: 10.1007/s10353-018-0527-z. pii: 527. pmc: PMC6290852 |
PMID: 30559831 |
Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction-The EMMY trial. |
Tripolt NJ, Kolesnik E, Pferschy PN, Verheyen N, Ablasser K, Sailer S, Alber H, Berger R, Kaulfersch C, Leitner K, Lichtenauer M, Mader A, Moertl D, Oulhaj A, Reiter C, Rieder T, Saely CH, Siller-Matula J, Weidinger F, Zechner PM, von Lewinski D, Sourij H |
American heart journal. 2019 Dec 12. pii: S0002-8703(19)30344-8. doi: 10.1016/j.ahj.2019.12.004 |
PMID: 31901799 |
Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial. |
Dachs TM, Duca F, Rettl R, Binder-Rodriguez C, Dalos D, Ligios LC, Kammerlander A, Grünig E, Pretsch I, Steringer-Mascherbauer R, Ablasser K, Wargenau M, Mascherbauer J, Lang IM, Hengstenberg C, Badr-Eslam R, Kastner J, Bonderman D |
European heart journal. 2022 Aug 1. pii: 6652608. doi: 10.1093/eurheartj/ehac389 |
PMID: 35909264 |
13 Einträge |
Seite 1 / 1
![]() |